Aptevo Therapeutics (NASDAQ:APVO) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Aptevo Therapeutics (APVO) operate in?

Aptevo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Aptevo Therapeutics Stock (NASDAQ: APVO) stock price, news, charts, stock research, profile.

Open	$3.38
Close	$3.47
Volume / Avg.	29.17K / 207.53K
Day Range	$3.32 - $3.58
52 Wk Range	3.01 - 399.60
Market Cap	$4.83M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	30
Short Interest	2.99%
Days to Cover	1

Recent News

What's Going On With Aptevo Therapeutics Shares Friday?

Aptevo stock is trading lower after the company announced a 1-for-37 reverse stock split.

Dylan Berman

Dow Tumbles Over 250 Points; Boeing Posts Q3 Loss

Avi Kapoor

Why Stride Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$3.38
Close	$3.47
Volume / Avg.	29.17K / 207.53K
Day Range	$3.32 - $3.58
52 Wk Range	3.01 - 399.60
Market Cap	$4.83M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	30
Short Interest	2.99%
Days to Cover	1

About Aptevo Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused o...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Aptevo Therapeutics (APVO) stock?

You can purchase shares of Aptevo Therapeutics (NASDAQ:APVO) through any online brokerage.

View our list of the best stock brokerages

Who are Aptevo Therapeutics (APVO) competitors?

Other companies in Aptevo Therapeutics’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Syros Pharmaceuticals (NASDAQ:SYRS), Galecto (NASDAQ:GLTO), Alzamend Neuro (NASDAQ:ALZN) and Dermata Therapeutics (NASDAQ:DRMA).

What is the forecast, or price target, for Aptevo Therapeutics (APVO) stock?

Aptevo Therapeutics has a consensus price target of $14.00.

What is the current price for Aptevo Therapeutics (APVO)?

The stock price for Aptevo Therapeutics (NASDAQ: APVO) is $3.31 last updated February 21, 2025 at 5:57 PM EST.

Does Aptevo Therapeutics (APVO) pay a dividend?

There are no upcoming dividends for Aptevo Therapeutics.

When is Aptevo Therapeutics (NASDAQ:APVO) reporting earnings?

Aptevo Therapeutics’s Q1 earnings are confirmed for Wednesday, May 7, 2025.

Is Aptevo Therapeutics (APVO) going to split?

There is no upcoming split for Aptevo Therapeutics.

What sector and industry does Aptevo Therapeutics (APVO) operate in?

Aptevo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Aptevo Therapeutics

Aptevo Therapeutics (APVO) Forecast